HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okemoto, K. Articles by Nishijima, M. Search for Related Content PubMed PubMed Citation Articles by Okemoto, K. Articles by Nishijima, M.

A Potent Adjuvant Monophosphoryl Lipid A Triggers Various Immune Responses, but Not Secretion of IL-1 or Activation of Caspase-1¹

Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan

Lipid A, the membrane anchor portion of LPS, is responsible for the endotoxin activity of LPS and induces many inflammatory responses in macrophages. Monophosphoryl lipid A (MPL), a lipid A derivative lacking a phosphate residue, induces potent immune responses with low toxicity. To elucidate the mechanism underlying the low toxicity of MPL, we examined the effects of MPL on the secretion of proinflammatory cytokines by mouse peritoneal macrophages, a murine macrophage-like cell line (RAW 264.7), and a human macrophage-like cell line (THP-1). MPL enhanced the secretion of TNF-, but not that of IL-1, whereas Escherichia coli-type lipid A (natural source-derived and chemically synthesized lipid A) enhanced the secretion of both cytokines. Although MPL enhanced the levels of IL-1 mRNA and IL-1 precursor protein to levels similar to those induced by lipid A, IL-1 precursor processing in MPL-treated cells was much lower than that in E. coli-type lipid A-treated ones. Moreover, MPL, unlike E. coli-type lipid A, failed to induce activation of caspase-1, which catalyzes IL-1 precursor processing. These results suggest that an immune response without activation of caspase-1 or secretion of IL-1 results in the low toxicity of this adjuvant.

This article has been cited by other articles:

				C. Cekic, C. R. Casella, C. A. Eaves, A. Matsuzawa, H. Ichijo, and T. C. Mitchell Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A J. Biol. Chem., November 13, 2009; 284(46): 31982 - 31991. [Abstract] [Full Text] [PDF]

				M. N. Burtnick, P. J. Brett, V. Nair, J. M. Warawa, D. E. Woods, and F. C. Gherardini Burkholderia pseudomallei Type III Secretion System Mutants Exhibit Delayed Vacuolar Escape Phenotypes in RAW 264.7 Murine Macrophages Infect. Immun., July 1, 2008; 76(7): 2991 - 3000. [Abstract] [Full Text] [PDF]

				R. S. Munford Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant? Infect. Immun., February 1, 2008; 76(2): 454 - 465. [Full Text] [PDF]

				J. Geurtsen, H. A. Banus, E. R. Gremmer, H. Ferguson, L. J. J. de la Fonteyne-Blankestijn, J. P. Vermeulen, J. A. M. A. Dormans, J. Tommassen, P. van der Ley, F. R. Mooi, et al. Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice Clin. Vaccine Immunol., July 1, 2007; 14(7): 821 - 829. [Abstract] [Full Text] [PDF]

				V. Mata-Haro, C. Cekic, M. Martin, P. M. Chilton, C. R. Casella, and T. C. Mitchell The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 Science, June 15, 2007; 316(5831): 1628 - 1632. [Abstract] [Full Text] [PDF]